Humeau Laurent 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Humeau Laurent
Chief Scientific Officer
Transactions
- Award
Common Stock Option
[F1]2026-03-04+26,840→ 26,840 totalExercise: $1.73Exp: 2036-02-26→ Common Stock (26,840 underlying) - Award
Restricted Stock Unit
[F2]2026-03-04+21,560→ 21,560 total→ Common Stock (21,560 underlying)
Footnotes (2)
- [F1]The vesting schedule for the 26,840 options granted on March 4, 2026 was as follows: 8,947 shares will vest on February 26, 2027; 8,947 shares will vest on February 26, 2028; 8,946 shares will vest on February 26, 2029.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Signature
/s/ Laurent Humeau|2026-03-05